Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(29%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_2
1
14%
Ph phase_4
5
71%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(5)

Detailed Status

Completed5
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 45 (83.3%)

Trials by Status

recruiting114%
active_not_recruiting114%
completed571%

Recent Activity

2 active trials
Showing 5 of 7
active_not_recruitingphase_4

Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study

NCT05185258
completedphase_4

Combination of Sotyktu and Enstilar for Plaque Psoriasis

NCT06329258
completedphase_2

Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails

NCT04580537
completedphase_4

The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients

NCT03848871
recruitingphase_4

Taltz in Combination With Enstilar for Psoriasis

NCT04372277
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05185258Phase 4

Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study

Active Not Recruiting
NCT06329258Phase 4

Combination of Sotyktu and Enstilar for Plaque Psoriasis

Completed
NCT04580537Phase 2

Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails

Completed
NCT03848871Phase 4

The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients

Completed
NCT04372277Phase 4

Taltz in Combination With Enstilar for Psoriasis

Recruiting
NCT02881346

Efficacy and Tolerability of Enstilar® in Daily Practice

Completed
NCT03441789Phase 4

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7